An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)

Inclusion Criteria: * Good physical and mental health; * Body Mass Index between 18 and 29 kg/m\^2; * Good venous accessibility; Exclusion Criteria: * Clinically relevant abnormal blood chemistry, hematology and/or urinalysis at screening; * Hypertension (sitting diastolic blood pressure \> 90 mmHg and/or systolic blood pressure \> 150 mmHg); * Contraindications for the use of oral contraceptives or gonadotropins; * PAP-smear (= III) according to the Papanicolaou classification; * History of endocrine abnormalities such as hyperprolactinaemia, polycystic ovary syndrome or any evidence of ovarian dysfunction; * Primary ovarian failure; * Ovarian cysts or enlarged ovaries, not related to polycystic ovarian disease; * Any ovarian and/or abdominal abnormality that would interfere with adequate ultrasound investigation; * Ovarian surgery; * Smoking more than 10 cigarettes or equivalents a day; * History (within 12 months) of alcohol or drugs abuse; * Blood donation (\> 200 ml) within 90 days prior to screening; * Administration of investigational drugs within 90 days prior to start Org 36286.